# Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia

> **NCT07369336** · PHASE4 · COMPLETED · sponsor: **Postgraduate Medical Institute, Lahore** · enrollment: 90 (actual)

## Conditions studied

- Ventilator Associated Pneumonia ( VAP)

## Interventions

- **DRUG:** Amikacin (Inhalation)
- **DRUG:** Standard-of-Care Intravenous Antibiotics

## Key facts

- **NCT ID:** NCT07369336
- **Lead sponsor:** Postgraduate Medical Institute, Lahore
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-05
- **Primary completion:** 2024-11-25
- **Final completion:** 2025-09-30
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07369336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07369336, "Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07369336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*